National Bank Of Canada Jazz Pharmaceuticals PLC Transaction History

National Bank Of Canada

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	SELL	$103.94 - $118.98 $26,088 - $29,863	-251 Reduced 63.54%	144 $15,000
Q1 2024 May 13, 2024	BUY	$115.19 - $132.77 $2,303 - $2,655	20 Added 5.33%	395 $47,000
Q4 2023 Feb 06, 2024	BUY	$114.26 - $136.0 $2,285 - $2,720	20 Added 5.63%	375 $46,000
Q3 2023 Oct 10, 2023	SELL	$122.0 - $145.31 $179,096 - $213,315	-1,468 Reduced 80.53%	355 $45,000
Q2 2023 Jul 26, 2023	BUY	$122.5 - $147.16 $123,725 - $148,631	1,010 Added 124.23%	1,823 $225,000
Q1 2023 Apr 12, 2023	SELL	$133.98 - $160.47 $251,614 - $301,362	-1,878 Reduced 69.79%	813 $118,000
Q4 2022 Jan 24, 2023	BUY	$129.72 - $159.85 $116,358 - $143,385	897 Added 50.0%	2,691 $0
Q2 2022 Jul 28, 2022	BUY	$141.59 - $168.66 $3,681 - $4,385	26 Added 1.47%	1,794 $280,000
Q1 2022 May 05, 2022	BUY	$129.64 - $160.7 $194,330 - $240,889	1,499 Added 557.25%	1,768 $275,000
Q4 2021 Jan 24, 2022	BUY	$119.87 - $145.67 $32,245 - $39,185	269 New	269 $35,000

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

Stay updated on National Bank Of Canada with notifications on news.